Sigma Planning Corp’s Actuate Therapeutics, Inc. Common stock ACTU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-23,675
Closed -$160K 1328
2025
Q1
$160K Buy
23,675
+7,600
+47% +$51.5K 0.01% 1132
2024
Q4
$128K Buy
+16,075
New +$128K ﹤0.01% 1118